Helius Medical Technologies’ groundbreaking PoNS device for short-term treatment of gait deficit due to multiple sclerosis has received marketing authorization from the U.S. Food and Drug Administration (FDA).
登壇者プロフィール
Jamie Taylor
この筆者のインサイト
Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test
Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test
DSP Concepts and Cambridge Consultants work to accelerate audio and voice innovation
Cambridge Consultants adds new IP to Audio Weaver, pushes audio boundaries, brings decades of integrated systems expertise